RecruitingNCT04754217
Valved Graft PMCF Study
Valved Graft Post-Market Clinical Follow-up Study
Sponsor
Abbott Medical Devices
Enrollment
260 participants
Start Date
Jul 13, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement
Exclusion Criteria3
- anticoagulation therapy intolerant
- active endocarditis
- anatomical or medical, surgical, psychological or social contraindications
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEVAVGJ
Replacement of the aortic valve and ascending aorta
DEVICECAVGJ
Replacement of the aortic valve and ascending aorta
Locations(25)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04754217
Related Trials
Aortopathy Relationship To Imagery and Kinocardiography Features (ARTIK)
NCT062863581 location
Cardiovascular Health Improvement Project
NCT023062001 location
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
NCT0682799016 locations
Prospective Long-Term Outcomes of a Standardized Ross Procedure
NCT063526711 location
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
NCT048641451 location